Logo COMBINE Group COMBINE Group In Silico BioMedicine
  • Home
  • About us
    • Team
    • Publications
  • News
  • Research
    • VACCINES AND IMMUNOTHERAPIES
    • IN SILICO CLINICAL TRIALS
    • PRECISION MEDICINE
  • Teaching
    • CdL
      • Biotechnology
      • SFA
    • CdLM
      • CTF
      • Farmacia
  • Events
    • CMISF 2022
    • CMISF 2021
    • CMISF 2020
    • CMISF 2019
    • CMISF 2018
    • CMISF 2017
  • Funding
  • Partners
  • Software
  • Jobs

MERCK

  1. Home
  2. Funding
  3. Projects

Quantitative modeling for neurodegenerative diseases: the case of multiple sclerosis

Project title: Quantitative modeling for neurodegenerative diseases: the case of multiple sclerosis

Starting date: October, 1st 2011.
Ending date: October, 1st 2014.

Project summary:
The Consultancy Agreement between the Merck KGaA and the University of Catania is focused on quantitative modeling of disease progression of neurodegenerative disease i.e., Multiple Sclerosis (MS), at cellular level and training of Merck employees on quantitative modeling.

© 2018 COMBINE Group - All rights reserved. | Created by MW Templates | Edited by Giuseppe Sgroi